Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Blood IL-6 is a critical trigger of depressive symptoms in a mouse model for human atopic dermatitis

ABSTRACT: Single-cell RNA sequencing was performed using hippocampal tissue from a mouse model of atopic dermatitis to identify hippocampal cell types responsive to IL-6. Hippocampi were obtained from dermatitis-free mice maintained under SPF conditions, and gene expression profiles were analyzed to characterize IL-6–related cellular features.

ORGANISM(S): Mus musculus

PROVIDER: GSE318233 | GEO | 2026/09/09

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Blood IL-6 is a critical trigger of depressive symptoms in a mouse model for human atopic dermatitis

Project description:Blood IL-6 is a critical trigger of depressive symptoms in a mouse model for human atopic dermatitis

| PRJNA1416943 | ENA

TWEAK mediates inflammation in experimental atopic dermatitis and psoriasis

Project description:Atopic dermatitis and psoriasis are driven by alternate type 2 and type 17 immune responses, but some proteins might be critical to both diseases. We show that a deficiency of the TNF superfamily molecule TWEAK (TNFSF12) in mice results in defective maintenance of atopic dermatitis-specific Th2 and psoriasis-specific Th17 cells in the skin, and impaired expression of disease-characteristic chemokines and cytokines, such as CCL17 and TSLP in atopic dermatitis, and CCL20 and IL-19 in psoriasis. The TWEAK receptor, Fn14, is upregulated in keratinocytes and dermal fibroblasts, and TWEAK induces these cytokines and chemokines alone and in synergy with the signature T helper cytokines of either disease, IL-13 and IL-17. Furthermore, subcutaneous injection of recombinant TWEAK into naïve mice induces cutaneous inflammation with histological and molecular signs of both diseases. TWEAK is therefore a critical contributor to skin inflammation and a possible therapeutic target in atopic dermatitis and psoriasis.

2017-05-01 | GSE96957 | GEO

mRNA expression of Atopic Dermatitis keratinocytes

Project description:mRNA array analysis of total RNA from primary kertinocytes from three healthy controls, three atopic dermatitis patients and three psoriasis patients was carried out

2012-06-01 | E-MTAB-728 | biostudies-arrayexpress

Effect of anti-IL-4 and anti-IL-13 vaccination in a mouse model of atopic dermatitis

Project description:The effect of anti-mouse IL-4 and/or anti-mouse IL-13 Kinoid vaccines was assessed in a model of atopic dermatitis. Mice were immunized with IL-4 and/or IL13 Kinoids (or the carrier protein CRM197 alone as control). Atopic dermatitis-like pathology was induced by repeated epicutaneous exposures to house dust mite and the enterotoxin B from Staphylococcus aureus (SEB). Lesional skin biopsies were collected for bulk RNA sequencing analysis.

2025-12-10 | GSE290968 | GEO

Atopic Dermatitis Research Network

Project description:Atopic Dermatitis Research Network

| PRJNA714989 | ENA

Profiling of serum microRNAs in children with atopic dermatitis

Project description:Atopic dermatitis (AD) is the most prevalent chronic inflammatory skin disease in children characterized by dermatitis and pruritus. MicroRNAs (miRNAs) have been shown as great potential biomarkers for disease fingerprints to predict prognostics. We aimed to identify miRNA signature from serum and urine for the prognosis of AD patient by genome-wide miRNA profiling analysis. Serum from 8 children with AD and 8 healthy children were collected

2014-10-17 | E-GEOD-62404 | biostudies-arrayexpress

Profiling of urinary microRNAs in children with atopic dermatitis

Project description:Atopic dermatitis (AD) is the most prevalent chronic inflammatory skin disease in children characterized by dermatitis and pruritus. MicroRNAs (miRNAs) have been shown as great potential biomarkers for disease fingerprints to predict prognostics. We aimed to identify miRNA signature from serum and urine for the prognosis of AD patient by genome-wide miRNA profiling analysis. Urine from 3 children with AD and 3 healthy children were collected

2014-10-17 | E-GEOD-62403 | biostudies-arrayexpress

TWEAK Upregulates atopic dermatitis related genes

Project description:TWEAK Upregulates atopic dermatitis related genes in human kearatinocytes

2023-11-28 | GSE214503 | GEO

Identification of Pre-Disease State in NC/Nga Mice with Atopic dermatitis-like Symptoms using Dynamical Network Biomarkers

Project description:Atopic dermatitis (AD) is a common skin disease worldwide that is characterized by itchy eczema that undergoes cycles of exacerbation and remission. Although several biomarkers reflect AD severity, reliable markers for predicting disease onset and recurrence remain unclear. The dynamical network biomarker theory detects pre-disease states or pre-symptomatic states by analyzing characteristic network fluctuations just before phase transitions from healthy states to disease states. To investigate the applicability of dynamical network biomarker theory to AD, we conducted blood transcriptome analysis in NC/Nga mice before and after the onset of AD-like dermatitis. We identified 356 dynamical network biomarker genes whose temporal fluctuations enabled the detection of the pre-disease state preceding AD-like dermatitis onset. These genes were significantly enriched in pathways related to endoplasmic reticulum stress and apoptosis; fluctuations in these pathways may be associated with the onset of AD. Our study indicates that the dynamical network biomarker theory may be applicable to AD and that identifying a pre-disease state may enable early intervention and disease prevention. Collectively, this approach could provide valuable insights into maintaining long-term remission and improving AD management strategies.

2025-09-09 | GSE295168 | GEO

Atopic dermatitis epidermis PCT-DIA

Project description:Atopic Dermatitis (AD) is the most common inflammatory skin disease and characterized by a deficient epidermal barrier and cutaneous inflammation. Genetic studies suggest a key role of keratinocytes in AD pathogenesis, but the alterations in the proteome that occur in the entire epidermis have not been defined. Employing a pressure-cycling technology-data-independent acquisition (PCT-DIA) approach, we performed quantitative proteomics of epidermis from healthy volunteers and lesional and non-lesional skin of AD patients. Results were validated by targeted proteomics using parallel reaction monitoring mass spectrometry or by immunofluorescence staining. The identified proteins reflect the strong inflammation in lesional skin and the defect in keratinocyte differentiation and epidermal stratification. Most importantly, they reveal impaired activation of the NRF2-antioxidant pathway and reduced abundance of mitochondrial proteins involved in key metabolic pathways in the epidermis. These results provide insight into the molecular alterations in the epidermis of AD patients and identify novel targets for pharmaceutical intervention.

2022-10-04 | PXD025431 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data